Fracture liaison service to reduce postoperative complications and to improve activity of patients with hip fracture 24 months' follow-up survey

Fracture liaison service to reduce postoperative complications and to improve activity of patients with hip fracture 24 months' follow-up survey - Fracture liaison service to reduce postoperative complications and to improve activity of patients with hip fracture 24 months' follow-up survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000041206

Enrollment

500

Registered

2020-07-24

Start date

2015-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture, neck fracture and trochnateric fracture

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with fragility hip fracture

Exclusion criteria

Exclusion criteria: Pathological fracture, high energy injury

Design outcomes

Primary

Measure	Time frame
Age (in years), sex, the days from injury to surgery, and the rate at which surgery occurred within 36 hours from injury, number and rate of cases that had undergone any surgery, and average hospital stay (days) were recorded. Additionally, comorbidity at surgery (as classified in our previous study: hypertension, cardiovascular disease, pulmonary disease, renal disease, diabetes, cerebrovascular disease, digestive disease), complications newly occurring after admission, including those that involved worsening of a comorbidity, and hip fracture on the opposite side within 12 months and within 24 months after the first hip fracture were also investigated. We also examined the rate of taking anti-osteoporosis medicine, activities of daily living as evaluated by the Barthel index (BI) , and the rate of the patients whose BI was 80 and more, which was considered as indicator of independent daily activity. These parameters were evaluated at the time before injury, and 3 months, 6 months, 12 months, and 24 months after their injury. Moreover, mortality was examined within 1 month, 12 months, and 24 months after their injury, respectively. In terms of taking anti-osteoporosis medicine and activity of daily living as evaluated by the BI, the patients who died and who could not be traced were excluded from the analysis at each time-point. These data were obtained from medical records and telephone calls or by mail to the patients or their family, by a specialized liaison nurse qualified by the Japan Osteoporosis Society.	—

Measure

Time frame

Age (in years), sex, the days from injury to surgery, and the rate at which surgery occurred within 36 hours from injury, number and rate of cases that had undergone any surgery, and average hospital stay (days) were recorded. Additionally, comorbidity at surgery (as classified in our previous study: hypertension, cardiovascular disease, pulmonary disease, renal disease, diabetes, cerebrovascular disease, digestive disease), complications newly occurring after admission, including those that involved worsening of a comorbidity, and hip fracture on the opposite side within 12 months and within 24 months after the first hip fracture were also investigated. We also examined the rate of taking anti-osteoporosis medicine, activities of daily living as evaluated by the Barthel index (BI) , and the rate of the patients whose BI was 80 and more, which was considered as indicator of independent daily activity. These parameters were evaluated at the time before injury, and 3 months, 6 months, 12 months, and 24 months after their injury. Moreover, mortality was examined within 1 month, 12 months, and 24 months after their injury, respectively. In terms of taking anti-osteoporosis medicine and activity of daily living as evaluated by the BI, the patients who died and who could not be traced were excluded from the analysis at each time-point. These data were obtained from medical records and telephone calls or by mail to the patients or their family, by a specialized liaison nurse qualified by the Japan Osteoporosis Society.

—

Countries

Japan

Contacts

Public ContactNorio IMAI

Niigata University Graduate School of Medical and Dental Sciences, Japan Division of Comprehensice Muscloskeletal Medicine,

imainorio2001@med.niigata-u.ac.jp0252272272

Outcome results